182 related articles for article (PubMed ID: 31243343)
21. Wild-Type P53 Induces Sodium/Iodide Symporter Expression Allowing Radioiodide Therapy in Anaplastic Thyroid Cancer.
Liu L; Li D; Chen Z; Yang J; Ma Y; Cai H; Shan C; Lv Z; Zhang X
Cell Physiol Biochem; 2017; 43(3):905-914. PubMed ID: 28957796
[TBL] [Abstract][Full Text] [Related]
22. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.
von Roemeling CA; Marlow LA; Pinkerton AB; Crist A; Miller J; Tun HW; Smallridge RC; Copland JA
J Clin Endocrinol Metab; 2015 May; 100(5):E697-709. PubMed ID: 25675381
[TBL] [Abstract][Full Text] [Related]
23. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma.
Wang Z; Qiu X; Zhang H; Li W
J Biochem Mol Toxicol; 2020 May; 34(5):e22469. PubMed ID: 32173973
[TBL] [Abstract][Full Text] [Related]
24. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A
Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633
[TBL] [Abstract][Full Text] [Related]
25. miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A.
Shao M; Geng Y; Lu P; Xi Y; Wei S; Wang L; Fan Q; Ma W
Biochem Biophys Res Commun; 2015 Sep; 464(4):1309-1313. PubMed ID: 26231799
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation.
Zhong Z; Hu Z; Jiang Y; Sun R; Chen X; Chu H; Zeng M; Sun C
Oncotarget; 2016 Sep; 7(37):59652-59663. PubMed ID: 27487122
[TBL] [Abstract][Full Text] [Related]
27. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.
Jung CW; Han KH; Seol H; Park S; Koh JS; Lee SS; Kim MJ; Choi IJ; Myung JK
Int J Clin Exp Pathol; 2015; 8(1):560-8. PubMed ID: 25755746
[TBL] [Abstract][Full Text] [Related]
28. LINC00886 Negatively Regulates Malignancy in Anaplastic Thyroid Cancer.
Ma B; Luo Y; Xu W; Han L; Liu W; Liao T; Yang Y; Wang Y
Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36726346
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z
Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257
[TBL] [Abstract][Full Text] [Related]
30. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.
Saini S; Sripada L; Tulla K; Kumar P; Yue F; Kunda N; Maker AV; Prabhakar BS
Cell Death Dis; 2019 Feb; 10(2):145. PubMed ID: 30760700
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.
Yu XM; Jaskula-Sztul R; Ahmed K; Harrison AD; Kunnimalaiyaan M; Chen H
Mol Cancer Ther; 2013 Jul; 12(7):1276-87. PubMed ID: 23594881
[TBL] [Abstract][Full Text] [Related]
32. SRY‑related HMG box‑2 role in anaplastic thyroid cancer aggressiveness is related to the fibronectin 1 and PI3K/AKT pathway.
Wang P; Shang J; Zhao J; Wang K; Guo L; Gu J; Wang W
Mol Med Rep; 2020 Mar; 21(3):1201-1207. PubMed ID: 31922212
[TBL] [Abstract][Full Text] [Related]
33. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway.
Li X; Amazit L; Long W; Lonard DM; Monaco JJ; O'Malley BW
Mol Cell; 2007 Jun; 26(6):831-42. PubMed ID: 17588518
[TBL] [Abstract][Full Text] [Related]
35. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer.
Zhou M; Chen Y; Adachi M; Wen X; Erwin B; Mawlawi O; Lai SY; Li C
Biomaterials; 2015 Jul; 57():41-9. PubMed ID: 25913249
[TBL] [Abstract][Full Text] [Related]
36. KAT5 promotes invasion and metastasis through C-MYC stabilization in ATC.
Wei X; Cai S; Boohaker RJ; Fried J; Li Y; Hu L; Pan Y; Cheng R; Zhang S; Tian Y; Gao M; Xu B
Endocr Relat Cancer; 2019 Jan; 26(1):141-151. PubMed ID: 30400007
[TBL] [Abstract][Full Text] [Related]
37. REGγ Is Associated with Lymph Node Metastasis and T-Stage in Papillary Thyroid Carcinoma.
Qi L; He W
Med Sci Monit; 2018 Mar; 24():1373-1378. PubMed ID: 29509725
[TBL] [Abstract][Full Text] [Related]
38. REGγ is associated with multiple oncogenic pathways in human cancers.
He J; Cui L; Zeng Y; Wang G; Zhou P; Yang Y; Ji L; Zhao Y; Chen J; Wang Z; Shi T; Zhang P; Chen R; Li X
BMC Cancer; 2012 Feb; 12():75. PubMed ID: 22361172
[TBL] [Abstract][Full Text] [Related]
39. Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells.
Chin LH; Hsu SP; Zhong WB; Liang YC
Mol Carcinog; 2016 May; 55(5):622-32. PubMed ID: 25773758
[TBL] [Abstract][Full Text] [Related]
40. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]